[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Liver Failure Therapeutics Market Status and Outlook 2018-2025

August 2018 | 124 pages | ID: G9E56A36D24EN
99Strategy

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Snapshot

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1: Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2: Upstream (Raw Materials / Components) & Manufacturing (Procurement Methods & Channels and Cost) , Major Regional Production Overview and Trade Flow
Part 3: Product Segment Overview and Market Status
Part 4: Application / End-User Segment Overview and Market Status
Part 5: Region Segment Overview and Market Status
Part 6: Product & Application Segment Production & Demand by Region
Part 7: Market Forecast by Product, Application & Region
Part 8: Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9: Market Competition and Environment for New Entrants
Part 10: Conclusion

Market Segment as follows:

Key Companies
  • Alfact Innovation
  • BioLineRx Ltd
  • Cell2B Advanced Therapeutics SA
  • Conatus Pharmaceuticals Inc
  • Immune Pharmaceuticals Inc
  • Mina Therapeutics Ltd
  • Mylan NV
  • Ocera Therapeutics Inc
  • PledPharma AB
  • Promethera Biosciences SA
  • Silence Therapeutics Plc
  • Unicyte AG
  • Ventria Bioscience
  • Vital Therapies Inc
Market by Type
  • Ornithine Phenylacetate
  • MTL-CEBPA
  • F-573
  • BL-1220
  • PP-100
  • Others
Market by Application
  • Clinic
  • Hospital
  • Others
PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 Liver Failure Therapeutics Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 Ornithine Phenylacetate
  3.1.2 MTL-CEBPA
  3.1.3 F-573
  3.1.4 BL-1220
  3.1.5 PP-100
  3.1.6 Others
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Clinic
  4.1.2 Hospital
  4.1.3 Others
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sudan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 Ornithine Phenylacetate Production by Region
    6.1.1.2 MTL-CEBPA Production by Region
    6.1.1.3 F-573 Production by Region
    6.1.1.4 BL-1220 Production by Region
    6.1.1.5 PP-100 Production by Region
    6.1.1.6 Others Production by Region
  6.1.2 Production by Application
    6.1.2.1 Clinic Production by Region
    6.1.2.2 Hospital Production by Region
    6.1.2.3 Others Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 Ornithine Phenylacetate Demand by Region
    6.2.1.2 MTL-CEBPA Demand by Region
    6.2.1.3 F-573 Demand by Region
    6.2.1.4 BL-1220 Demand by Region
    6.2.1.5 PP-100 Demand by Region
    6.2.1.6 Others Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Clinic Demand by Region
    6.2.2.2 Hospital Demand by Region
    6.2.2.3 Others Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 Alfact Innovation
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 BioLineRx Ltd
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 Cell2B Advanced Therapeutics SA
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation
8.4 Conatus Pharmaceuticals Inc
  8.4.1 Company Information
  8.4.2 Products & Services
  8.4.3 Business Operation
8.5 Immune Pharmaceuticals Inc
  8.5.1 Company Information
  8.5.2 Products & Services
  8.5.3 Business Operation
8.6 Mina Therapeutics Ltd
  8.6.1 Company Information
  8.6.2 Products & Services
  8.6.3 Business Operation
8.7 Mylan NV
  8.7.1 Company Information
  8.7.2 Products & Services
  8.7.3 Business Operation
8.8 Ocera Therapeutics Inc
  8.8.1 Company Information
  8.8.2 Products & Services
  8.8.3 Business Operation
8.9 PledPharma AB
  8.9.1 Company Information
  8.9.2 Products & Services
  8.9.3 Business Operation
8.10 Promethera Biosciences SA
  8.10.1 Company Information
  8.10.2 Products & Services
  8.10.3 Business Operation
8.11 Silence Therapeutics Plc
8.12 Unicyte AG
8.13 Ventria Bioscience
8.14 Vital Therapies Inc

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

LIST OF TABLES

Table Liver Failure Therapeutics Industry Dynamics & Regulations List
Table Global Liver Failure Therapeutics Sales Revenue, Cost and Margin, 2015-2018E
Table Global Liver Failure Therapeutics Market Status by Type 2015-2018E, in USD Million
Table Global Liver Failure Therapeutics Market Status by Application 2015-2018E, in USD Million
Table Global Liver Failure Therapeutics Market Status by Application 2015-2018E, in Volume
Table Global Liver Failure Therapeutics Market by Region 2015-2018E, in USD Million
Table Global Liver Failure Therapeutics Market Share by Region in 2018, in USD Million
Table Global Liver Failure Therapeutics Market by Region 2015-2018E, in Volume
Table Global Liver Failure Therapeutics Market Share by Region in 2018, in Volume
Table Ornithine Phenylacetate Production Value by Region 2015-2018E, in USD Million
Table Ornithine Phenylacetate Production Volume by Region 2015-2018E, in Volume
Table MTL-CEBPA Production Value by Region 2015-2018E, in USD Million
Table MTL-CEBPA Production Volume by Region 2015-2018E, in Volume
Table F-573 Production Value by Region 2015-2018E, in USD Million
Table F-573 Production Volume by Region 2015-2018E, in Volume
Table BL-1220 Production Value by Region 2015-2018E, in USD Million
Table BL-1220 Production Volume by Region 2015-2018E, in Volume
Table PP-100 Production Value by Region 2015-2018E, in USD Million
Table PP-100 Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table Clinic Production Value by Region 2015-2018E, in USD Million
Table Clinic Production Volume by Region 2015-2018E, in Volume
Table Hospital Production Value by Region 2015-2018E, in USD Million
Table Hospital Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table Ornithine Phenylacetate Market Size by Region 2015-2018E, in USD Million
Table Ornithine Phenylacetate Market Size by Region 2015-2018E, in Volume
Table MTL-CEBPA Market Size by Region 2015-2018E, in USD Million
Table MTL-CEBPA Market Size by Region 2015-2018E, in Volume
Table F-573 Market Size by Region 2015-2018E, in USD Million
Table F-573 Market Size by Region 2015-2018E, in Volume
Table BL-1220 Market Size by Region 2015-2018E, in USD Million
Table BL-1220 Market Size by Region 2015-2018E, in Volume
Table PP-100 Market Size by Region 2015-2018E, in USD Million
Table PP-100 Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table Clinic Market Size by Region 2015-2018E, in USD Million
Table Clinic Market Size by Region 2015-2018E, in Volume
Table Hospital Market Size by Region 2015-2018E, in USD Million
Table Hospital Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table GlobalLiver Failure Therapeutics Forecast by Type 2019F-2025F, in USD Million
Table Liver Failure Therapeutics Forecast by Type 2019F-2025F, in Volume
Table Liver Failure Therapeutics Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table Liver Failure Therapeutics Market Forecast by Application / End-User 2019F-2025F, in Volume
Table Liver Failure Therapeutics Market Forecast by Region 2019F-2025F, in USD Million
Table Liver Failure Therapeutics Market Forecast by Region 2019F-2025F, in Volume
Table Alfact Innovation Information
Table Liver Failure Therapeutics Sales, Cost, Margin of Alfact Innovation
Table BioLineRx Ltd Information
Table Liver Failure Therapeutics Sales, Cost, Margin of BioLineRx Ltd
Table Cell2B Advanced Therapeutics SA Information
Table Liver Failure Therapeutics Sales, Cost, Margin of Cell2B Advanced Therapeutics SA
Table Conatus Pharmaceuticals Inc Information
Table Liver Failure Therapeutics Sales, Cost, Margin of Conatus Pharmaceuticals Inc
Table Immune Pharmaceuticals Inc Information
Table Liver Failure Therapeutics Sales, Cost, Margin of Immune Pharmaceuticals Inc
Table Mina Therapeutics Ltd Information
Table Liver Failure Therapeutics Sales, Cost, Margin of Mina Therapeutics Ltd
Table Mylan NV Information
Table Liver Failure Therapeutics Sales, Cost, Margin of Mylan NV
Table Ocera Therapeutics Inc Information
Table Liver Failure Therapeutics Sales, Cost, Margin of Ocera Therapeutics Inc
Table PledPharma AB Information
Table Liver Failure Therapeutics Sales, Cost, Margin of PledPharma AB
Table Promethera Biosciences SA Information
Table Liver Failure Therapeutics Sales, Cost, Margin of Promethera Biosciences SA
Table Silence Therapeutics Plc Information
Table Liver Failure Therapeutics Sales, Cost, Margin of Silence Therapeutics Plc
Table Unicyte AG Information
Table Liver Failure Therapeutics Sales, Cost, Margin of Unicyte AG
Table Ventria Bioscience Information
Table Liver Failure Therapeutics Sales, Cost, Margin of Ventria Bioscience
Table Vital Therapies Inc Information
Table Liver Failure Therapeutics Sales, Cost, Margin of Vital Therapies Inc
Table Global Liver Failure Therapeutics Sales Revenue by Company 2015-2017, in USD Million
Table Global Liver Failure Therapeutics Sales Volume by Company 2015-2017, in Volume
Table Global Liver Failure Therapeutics Sales Volume by Company in 2018, in Volume

LIST OF FIGURES

Figure Liver Failure Therapeutics Picture
Figure Liver Failure Therapeutics Industry Chain Diagram
Figure Global Liver Failure Therapeutics Sales Revenue 2015-2018E, in USD Million
Figure Global Liver Failure Therapeutics Sales Volume 2015-2018E, in Volume
Figure Global Liver Failure Therapeutics Market Status by Type 2015-2018E, in Volume
Figure North America Liver Failure Therapeutics Market Size and Growth 2015-2018E, in USD Million
Figure North America Liver Failure Therapeutics Market Size and Growth 2015-2018E, in Volume
Figure Europe Liver Failure Therapeutics Market Size and Growth 2015-2018E, in USD Million
Figure Europe Liver Failure Therapeutics Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific Liver Failure Therapeutics Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific Liver Failure Therapeutics Market Size and Growth 2015-2018E, in Volume
Figure South America Liver Failure Therapeutics Market Size and Growth 2015-2018E, in USD Million
Figure South America Liver Failure Therapeutics Market Size and Growth 2015-2018E, in Volume
Figure Middle East Liver Failure Therapeutics Market Size and Growth 2015-2018E, in USD Million
Figure Middle East Liver Failure Therapeutics Market Size and Growth 2015-2018E, in Volume
Figure Africa Liver Failure Therapeutics Market Size and Growth 2015-2018E, in USD Million
Figure Africa Liver Failure Therapeutics Market Size and Growth 2015-2018E, in Volume
Figure Global Liver Failure Therapeutics Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global Liver Failure Therapeutics Sales Volume Forecast 2019F-2025F, in Volume
Figure Global Liver Failure Therapeutics Sales Price Forecast 2019F-2025F
Figure Global Liver Failure Therapeutics Gross Margin Forecast 2019F-2025F
Figure Global Liver Failure Therapeutics Sales Revenue by Company in 2018, in USD Million
Figure Global Liver Failure Therapeutics Price by Company in 2018
Figure Global Liver Failure Therapeutics Gross Margin by Company in 2018


More Publications